Image: Delfina Care

Delfina Care, a healthcare technology company focused on addressing the maternal health crisis, has raised $17 million in Series A funding led by U.S. Venture Partners (USVP). The round included participation from ARTIS Ventures, Mayo Clinic, Tokio Marine Future Fund, and existing investors including Story Ventures, SemperVirens, Bread and Butter Ventures, Boutique Ventures, and Chelsea Clinton’s Metrodora Ventures.

The company’s AI-powered platform combines predictive analytics with tailored interventions to improve maternal and infant health outcomes. Delfina partners have reported reductions in preterm births, NICU admissions, hypertensive disorders, and gestational diabetes – key factors in maternal morbidity and mortality. Based on these improvements, the company guarantees 3X cost savings for health plans.

“This funding marks a significant milestone in Delfina’s fulfillment of our mission to solve the national maternal health crisis,” said Senan Ebrahim, MD, PhD, CEO and Founder of Delfina. “We are grateful for the support of our investors and partners who share our commitment to improving outcomes for moms and babies. With this capital, Delfina will accelerate serving diverse populations, scale our impact nationally, and evolve our market-leading AI-powered predictive technology to continue delivering proven results for our partners nationwide.”

The funding comes at a critical time in U.S. maternal health. In 2021, the maternal mortality rate reached 32.9 deaths per 100,000 live births—more than double that of other high-income countries. The crisis disproportionately affects Black women, who face a maternal mortality rate nearly three times higher than white women and a preterm birth rate 1.4 times higher.

“Since we transformed our practice with Delfina Care, we have seen the positive impact on our pregnant patients’ care every day,” said Fatimah Lalani, DO, Chief Medical Officer of HOPE Clinic in Houston, Texas. “We see many patients whose cardiovascular and metabolic challenges we can now proactively manage thanks to Delfina’s insights. Our clinicians have been empowered by Delfina’s system to efficiently provide a new level of proactive care for healthy pregnancy outcomes.”

The new funding will support national expansion, further development of the company’s AI technology, and continued partnerships with healthcare providers across the country.

Show CommentsClose Comments

Leave a comment